On-Demand Webinars

  1. A New Chapter for Orexin Therapies: What's Changing in Drug Development 9/16/2026

    Join Beatrice Setnik, PhD and Denise Milova, PhD, for a conversation on orexin rescheduling and the evolving regulatory landscape.

  2. Scaling AAV Manufacturing To 1000 L: Strategies For Robust Production 9/15/2026

    Learn how integrated cell line, media, and process design can support consistent AAV production at larger volumes while maintaining productivity and quality, as well as reducing scale-up risk.

  3. The Next Generation Of USP <87> Testing 9/14/2026

    Upcoming USP <87> changes are driving risk-based in vitro testing. Learn how to prepare for new requirements, validation impacts, and continued compliance.

  4. Reducing Timelines And Development Costs Through Scale Up 9/11/2026

    See how an engineering-based approach to bioreactor scale-up delivered comparable cell growth, metabolic profiles, and product performance across cell lines and vessel sizes, helping reduce risks.

  5. Scaling AAV Purification: UF/DF Technologies That Deliver 9/11/2026

    Examine a data-driven comparison of hollow-fiber and flat-sheet TFF technologies for AAV manufacturing, covering process performance, scalability, engineering considerations, and cost.

  6. Continuous Lyophilization: Accelerating Freeze-Drying Development 9/9/2026

    Continuous lyophilization is compressing freeze-drying cycle times from days to hours. This webinar examines how the approach is being implemented in development labs with a path to GMP manufacturing.

  7. Beyond Breakdowns: Building A Culture Of Proactive Maintenance 9/8/2026

    Reactive maintenance can drive costly downtime, deviations, and reliability challenges. Learn how proactive maintenance strategies help improve equipment uptime and strengthen compliance.

  8. Overcome Early Development Challenges Before They Impact Your Program 9/3/2026

    Poor manufacturability and immunogenicity can delay development. Learn how early developability assessments support IND readiness.

  9. How Sponsors Should Evaluate Manufacturing Resilience 9/3/2026

    Learn how continuity planning, technology transfer capabilities, global network flexibility, and digital visibility contribute to resilient supply chains and help protect programs from disruption.

  10. Intensification Of Upstream Operations With Dynamic Perfusion 9/3/2026

    Dynamic perfusion simplifies continuous cell culture by eliminating cell bleed. Compare upstream strategies across productivity to understand their potential for more efficient mAb production.